Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Melissa Orilall is recorded as CFO at MiNK Therapeutics, Inc. (INKT). MiNK Therapeutics, Inc. reported in an 8-K filed March 19, 2026 that Melissa Orilall was appointed Principal Financial Officer, effective March 13, 2026. Melissa Orilall has spoken on 2 earnings calls across 1 company, most recently for MiNK Therapeutics, Inc. on August 13, 2026.
“Effective March 13, 2026, MiNK Therapeutics Inc.'s (the "Company") Board of Directors appointed Melissa Orilall, Agenus Inc.'s ("Agenus") current Vice President, Global Financial Operations to serve as the Company's Principal Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-03-13–present
Source not stated
Recorded roles and call appearances connecting this person to public companies.
CFO
2026-03-13–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
